Innovus Pharma Announces Availability Of Ejectdelay™ For Premature Ejaculation In The United States

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced the availability of its over the counter ("OTC") benzocaine-based topical premature ejaculation treatment EjectDelay™ in the United States ("U.S.").

Help employers find you! Check out all the jobs and post your resume.

Back to news